A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.

about

A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus.

Item

http://www.wikidata.org/entity/Q43260832

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@en

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@nl

type

Item

label

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@en

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@nl

prefLabel

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@en

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@nl

P1476

A case of herpes zoster during ...... cutaneous lupus erythematosus.

@en

P2093

Cemile Eren

http://www.w3.org/2001/XMLSchema#string

Damla Atacan

http://www.w3.org/2001/XMLSchema#string

Fatma Eskioglu

http://www.w3.org/2001/XMLSchema#string

Filiz Canpolat

http://www.w3.org/2001/XMLSchema#string

Semih Tatlican

http://www.w3.org/2001/XMLSchema#string

Umut Dalgic

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.

Pimecrolimus 1% cream for cutaneous lupus erythematosus.

Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity.

Activation and inhibition of virus and interferon: the herpesvirus story.

Infectious complications in SLE after immunosuppressive therapies.

Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis.

Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings.

Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years.

Pimecrolimus, yet another intriguing topical immunomodulator.

Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

P304

322-323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09546630903287460

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38013963

http://www.w3.org/2001/XMLSchema#string

P698

19832287

http://www.w3.org/2001/XMLSchema#string

P921

Subacute cutaneous lupus erythematosus